Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial

被引：0

作者：

Broeckelmann, Paul J. ^{[1
]}

Buehnen, Ina ^{[1
]}

Herhaus, Peter ^{[2
]}

Meissner, Julia ^{[3
]}

Trautmann-Grill, Karolin ^{[4
]}

Mueller, Horst ^{[1
]}

Fuchs, Michael ^{[5
,6
]}

von Tresckow, Bastian ^{[7
]}

Borchmann, Peter ^{[8
]}

Engert, Andreas ^{[1
]}

Behringer, Karolin ^{[1
]}

机构：

[1] Univ Hosp Cologne, Dept Internal Med 1, German Hodgkin Study Grp GHSG, Cologne, Germany

[2] Tech Univ Munich, Clin & Policlin Internal Med 3, Sch Med, Klinikum Rechts Isar, Munich, Germany

[3] Univ Hosp Heidelberg, Med 5, Heidelberg, Germany

[4] Univ Hosp Carl Gustav Carus, Med Clin 1, Dresden, Germany

[5] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Dept Internal Med 1, Med Fac, Cologne, Germany

[6] Univ Hosp Cologne, Cologne, Germany

[7] West German Canc Ctr Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[8] Univ Hosp Cologne, Dept Internal Med 1, German Hodgkin Study Grp GHSG, Cologne, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-188734

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG NIVAHL Trial
Broeckelmann, Paul J.
Buehnen, Ina
Herhaus, Peter
Meissner, Julia
Trautmann, Karolin
Mueller, Horst
Fuchs, Michael
von Tresckow, Bastian
Borchmann, Peter
Engert, Andreas
Behringer, Karolin
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 115 - 115
[2] Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial
Broeckelmann, Paul J.
Buehnen, Ina
Herhaus, Peter
Meissner, Julia
Trautmann-Grill, Karolin
Mueller, Horst
Fuchs, Michael
von Tresckow, Bastian
Borchmann, Peter
Engert, Andreas
Behringer, Karolin
BLOOD, 2023, 142
[3] Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial
Broeckelmann, Paul J.
Buehnen, Ina
Meissner, Julia
Trautmann-Grill, Karolin
Herhaus, Peter
Halbsguth, Teresa, V
Schaub, Valdete
Kerkhoff, Andrea
Mathas, Stephan
Bormann, Matthias
Dickhut, Andreas
Kaul, Helen
Fuchs, Michael
Kobe, Carsten
Baues, Christian
Borchmann, Peter
Engert, Andreas
von Tresckow, Bastian
BLOOD, 2022, 140 : 1753 - 1755
[4] Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial
Brockelmann, Paul J.
Goergen, Helen
Keller, Ulrich
Meissner, Julia
Trautmann, Karolin
Halbsguth, Teresa V.
Sasse, Stephanie
Sokler, Martin
Kerkhoff, Andrea
Mathas, Stephan
Huttmann, Andreas
Bormann, Matthias
Zimmermann, Andreas
Fuchs, Michael
von Tresckow, Bastian
Baues, Christian
Rosenwald, Andreas
Klapper, Wolfram
Kobe, Carsten
Borchmann, Peter
Engert, Andreas
BLOOD, 2020, 136
[5] Metabolic Tumor Volume for Early Response Assessment in Early-Stage Unfavorable Hodgkin Lymphoma Treated with Nivolumab in the GHSG Nivahl Phase II Trial
Voltin, Conrad-Amadeus
Mettler, Jasmin
Mueller, Horst
Fuchs, Michael
Baues, Christian
Dietlein, Markus
Engert, Andreas
Borchmann, Peter
Kobe, Carsten
Brockelmann, Paul J.
BLOOD, 2019, 134
[6] Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma
Zhao, Shuang
Liu, Yanyan
Yao, Zhihua
Yan, Zheng
Yao, Shuna
Chu, Junfeng
Wang, Haiying
Zhang, Jiuyang
Zhang, Peipei
Zhou, Wenping
BLOOD, 2022, 140 : 6579 - 6580
[7] Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Voltin, Conrad-Amadeus
Mettler, Jasmin
van Heek, Lutz
Goergen, Helen
Mueller, Horst
Baues, Christian
Keller, Ulrich
Meissner, Julia
Trautmann-Grill, Karolin
Kerkhoff, Andrea
Fuchs, Michael
Sasse, Stephanie
von Tresckow, Bastian
Dietlein, Markus
Borchmann, Peter
Engert, Andreas
Kobe, Carsten
Broeckelmann, Paul J.
CLINICAL CANCER RESEARCH, 2021, 27 (02) : 402 - 407
[8] Clinical outcomes of relapsed Hodgkin lymphoma patients after contemporary first-line treatment: Results from the German Hodgkin Study Group (GHSG)
Brockelmann, P.
Muller, H.
Gillessen, S.
Yang, X.
Koppel, L.
Pilz, V
Marinello, P.
Kaskel, P.
Raut, M.
Fuchs, M.
Borchmann, P.
Engert, A.
von Tresckow, B.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 37 - 37
[9] Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial
Fuerstenau, Moritz
Rotbain, Emelie Curovic
Eurelings, Laura
Robrecht, Sandra
Van Tresckow, Julia
Giza, Adam
Gregor, Michael
Thornton, Patrick
Staber, Philipp Bernhard
Tadmor, Tamar
Lindstrom, Vesa
Juliusson, Gunnar
Janssens, Ann
Schneider, Christof
Noesslinger, Thomas
Andres, Martin
Schmidt, Adrian
Vandenberghe, Elisabeth
Shvidel, Lev
Poulsen, Christian Bjorn
Frederiksen, Henrik
Da Cunha-Bang, Caspar
Lotfi, Kourosh
Mous, Rogier
Chamuleau, Martine E. D.
Wu, Lung
Oosterveld, Margriet
Duque-Afonso, Jesus
Bogner, Christian
Wolff, Thomas
Schetelig, Johannes
Vehling-Kaiser, Ursula
van Roye, Christoph
Kutsch, Nadine
Fink, Anna Maria
Fischer, Kirsten
Holmes, Emily
Ritgen, Matthias
Tausch, Eugen
Stilgenbauer, Stephan
Hallek, Michael J.
Kater, Arnon P.
Niemann, Carsten Utoft
Levin, Mark-David
Eichhorst, Barbara F.
BLOOD, 2024, 144 : 3238 - 3240
[10] Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
Lazarovici, Julien
Amorim, Sandy
Bouabdallah, Krimo
Guidez, Stephanie
Molina, Lysiane
Morschhauser, Franck
Gac, Anne-Claire
Gastinne, Thomas
Laribi, Kamel
Launay, Vincent
Slama, Bohrane
Belmecheri, Nawel
Casasnovas, Rene-Olivier
Corby, Anne
Durot, Eric
Feugier, Pierre
Nicolas-Virelizier, Emmanuelle
Sibon, David
Berriolo-Riedinger, Alina
Edeline, Veronique
Vander Borght, Thierry
Damotte, Diane
Traverse-Glehen, Alexandra
Andre, Marc
Ribrag, Vincent
BLOOD, 2021, 138

← 1 2 3 4 5 →